76 related articles for article (PubMed ID: 8272157)
1. In vitro antiproliferative effect of interferon alpha in solid tumors: a potential predictive test.
Fuchsberger N; Kubes M; Kontsek P; Borecký L; Hornák M; Godál A; Silvanová ; Svec J
Neoplasma; 1993; 40(5):293-6. PubMed ID: 8272157
[TBL] [Abstract][Full Text] [Related]
2. Treatment with low-dose interferon-alpha restores the balance between matrix metalloproteinase-9 and E-cadherin expression in human transitional cell carcinoma of the bladder.
Slaton JW; Karashima T; Perrotte P; Inoue K; Kim SJ; Izawa J; Kedar D; McConkey DJ; Millikan R; Sweeney P; Yoshikawa C; Shuin T; Dinney CP
Clin Cancer Res; 2001 Sep; 7(9):2840-53. PubMed ID: 11555602
[TBL] [Abstract][Full Text] [Related]
3. Interferons modify in vitro proliferation of human bladder transitional cell carcinoma in the presence of doxorubicin and mitomycin C.
Okamoto E; Kinne RK; Sökeland J
J Urol; 1996 Oct; 156(4):1492-5. PubMed ID: 8808915
[TBL] [Abstract][Full Text] [Related]
4. Role of proliferative activity estimated by bromodeoxyuridine labeling index in determining predictive factors of recurrence in superficial intermediately malignant bladder tumors.
Tachibana M; Miyakawa A; Nakamura K; Baba S; Murai M; Tazaki H
J Urol; 1996 Jul; 156(1):63-9. PubMed ID: 8648839
[TBL] [Abstract][Full Text] [Related]
5. Correlation of clinical and immunological parameters of metastatic renal cell carcinoma patients undergoing therapy with interleukin 2, interferon-alpha and retinoic acid.
Elsässer-Beile U; Kölble N; Grussenmeyer T; Wetterauer U; Schultze-Seemann W
Anticancer Res; 1998; 18(3B):1883-90. PubMed ID: 9677439
[TBL] [Abstract][Full Text] [Related]
6. Interferon-alpha inhibits the DNA synthesis induced by PDGF and EGF in cultured meningioma cells.
Zhang ZJ; Muhr C; Wang JL
Anticancer Res; 1996; 16(2):717-23. PubMed ID: 8687119
[TBL] [Abstract][Full Text] [Related]
7. Influence of human leukocyte interferon (HuIFN-alpha/Le/) and cimetidine on the proliferation of cultured melanoma cells in vitro.
Flodgren P
Anticancer Res; 1985; 5(5):527-31. PubMed ID: 4062254
[TBL] [Abstract][Full Text] [Related]
8. Response assessment classification in patients with advanced renal cell carcinoma treated on clinical trials.
Schwartz LH; Mazumdar M; Wang L; Smith A; Marion S; Panicek DM; Motzer RJ
Cancer; 2003 Oct; 98(8):1611-9. PubMed ID: 14534876
[TBL] [Abstract][Full Text] [Related]
9. Synergistic antitumor effects of a combination of interferons and retinoic acid on human tumor cells in vitro and in vivo.
Lindner DJ; Borden EC; Kalvakolanu DV
Clin Cancer Res; 1997 Jun; 3(6):931-7. PubMed ID: 9815768
[TBL] [Abstract][Full Text] [Related]
10. Suppression of human ribosomal protein L23A expression during cell growth inhibition by interferon-beta.
Jiang H; Lin JJ; Tao J; Fisher PB
Oncogene; 1997 Jan; 14(4):473-80. PubMed ID: 9053844
[TBL] [Abstract][Full Text] [Related]
11. Antiproliferative effects of tyrosine kinase inhibitors (tyrphostins) on human bladder and renal carcinoma cells.
Sion-Vardy N; Vardy D; Rodeck U; Kari C; Levin RM; Malkowicz SB
J Surg Res; 1995 Dec; 59(6):675-80. PubMed ID: 8538164
[TBL] [Abstract][Full Text] [Related]
12. Pathologic features of bladder tumors after nephroureterectomy or segmental ureterectomy for upper urinary tract transitional cell carcinoma.
Raman JD; Sosa RE; Vaughan ED; Scherr DS
Urology; 2007 Feb; 69(2):251-4. PubMed ID: 17320658
[TBL] [Abstract][Full Text] [Related]
13. Impaired alpha-interferon signaling in transitional cell carcinoma: lack of p48 expression in 5637 cells.
Matin SF; Rackley RR; Sadhukhan PC; Kim MS; Novick AC; Bandyopadhyay SK
Cancer Res; 2001 Mar; 61(5):2261-6. PubMed ID: 11280796
[TBL] [Abstract][Full Text] [Related]
14. Dendritic cell therapy in combination with interferon-alpha for the treatment of metastatic renal cell carcinoma.
Tatsugami K; Eto M; Harano M; Hamaguchi M; Miyamoto T; Morisaki T; Furue M; Akashi K; Naito S
Int J Urol; 2008 Aug; 15(8):694-8. PubMed ID: 18564205
[TBL] [Abstract][Full Text] [Related]
15. Prospective, randomized, multicenter, double-blind placebo-controlled trial comparing adjuvant interferon alfa and isotretinoin with interferon alfa alone in stage IIA and IIB melanoma: European Cooperative Adjuvant Melanoma Treatment Study Group.
Richtig E; Soyer HP; Posch M; Mossbacher U; Bauer P; Teban L; Svolba G; Wolf IH; Fritsch P; Zelger B; Volc-Platzer B; Gebhart W; Mischer P; Steiner A; Pachinger W; Hintner H; Gschnait F; Rappersberger K; Pilarski P; Pehamberger H;
J Clin Oncol; 2005 Dec; 23(34):8655-63. PubMed ID: 16260701
[TBL] [Abstract][Full Text] [Related]
16. Effects of vitamin D (calcitriol) on transitional cell carcinoma of the bladder in vitro and in vivo.
Konety BR; Lavelle JP; Pirtskalaishvili G; Dhir R; Meyers SA; Nguyen TS; Hershberger P; Shurin MR; Johnson CS; Trump DL; Zeidel ML; Getzenberg RH
J Urol; 2001 Jan; 165(1):253-8. PubMed ID: 11125420
[TBL] [Abstract][Full Text] [Related]
17. The essential role of interferon-gamma during interleukin-12 therapy for murine transitional cell carcinoma of the bladder.
O'Donnell MA; Luo Y; Hunter SE; Chen X; Hayes LL; Clinton SK
J Urol; 2004 Mar; 171(3):1336-42. PubMed ID: 14767344
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of tumorigenicity and metastasis of human bladder cancer growing in athymic mice by interferon-beta gene therapy results partially from various antiangiogenic effects including endothelial cell apoptosis.
Izawa JI; Sweeney P; Perrotte P; Kedar D; Dong Z; Slaton JW; Karashima T; Inoue K; Benedict WF; Dinney CP
Clin Cancer Res; 2002 Apr; 8(4):1258-70. PubMed ID: 11948141
[TBL] [Abstract][Full Text] [Related]
19. [Response of superficial bladder carcinoma to prophylacit treatment with mitomycin-C versus interferon. Preliminary study].
Regueiro López JC; Alvarez-Cienfuegos FR; Leva Vallejo M; Prieto Castro R; Merchan García JA; Saceda López JL; Requena Tapia MJ; López-Pardo RL
Actas Urol Esp; 1993 May; 17(5):299-304. PubMed ID: 8342427
[TBL] [Abstract][Full Text] [Related]
20. Up-regulation of the interferon gamma (IFN-gamma)-inducible chemokines IFN-inducible T-cell alpha chemoattractant and monokine induced by IFN-gamma and of their receptor CXC receptor 3 in human renal cell carcinoma.
Suyama T; Furuya M; Nishiyama M; Kasuya Y; Kimura S; Ichikawa T; Ueda T; Nikaido T; Ito H; Ishikura H
Cancer; 2005 Jan; 103(2):258-67. PubMed ID: 15578685
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
